Medpace (MEDP) Superinvestor holders
25 of the superinvestors we track hold Medpace (MEDP) in their latest 13F filings, $2.5B in total.
Summary
The largest holder is Cliff Asness (AQR Capital Management), with $677M, 0.2% of the portfolio.
In their latest quarter: 2 opened a new position, 6 added, 17 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Trimmed | 1,278,935 | $677M | 0.2% | Q2 2026 |
| Wasatch Wasatch Global Investors |
Trimmed | 465,944 | $291M | 2.2% | Q3 2026 |
| Baillie Gifford Baillie Gifford & Co |
Trimmed | 451,764 | $282M | 0.3% | Q3 2026 |
| Arrowstreet Capital | Added | 429,012 | $227M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 415,588 | $220M | 0.3% | Q2 2026 |
| Francois Rochon Giverny Capital Inc. |
Trimmed | 253,931 | $134M | 4.5% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 234,537 | $124M | 0.1% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Added | 226,104 | $120M | 0.1% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 130,522 | $81M | 0.0% | Q3 2026 |
| C.T. Fitzpatrick Vulcan Value Partners |
Trimmed | 141,743 | $75M | 2.3% | Q2 2026 |
| James Robillard Spyglass Capital Management |
Added | 120,365 | $64M | 3.5% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Added | 86,715 | $46M | 0.4% | Q2 2026 |
| Terry Smith Fundsmith LLP |
Trimmed | 52,372 | $28M | 0.2% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | 37,598 | $20M | 0.0% | Q2 2026 |
| Jeremy Grantham GMO |
New position | 34,060 | $18M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 29,182 | $15M | 0.0% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 20,926 | $11M | 0.0% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 16,625 | $9M | 0.0% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
Trimmed | 15,605 | $8M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Trimmed | 9,740 | $5M | 0.0% | Q2 2026 |
| Peter Muller PDT Partners |
Trimmed | 6,355 | $3M | 0.2% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 2,971 | $2M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 2,773 | $1M | 0.0% | Q2 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 2,553 | $1M | 0.0% | Q2 2026 |
| Ken Tropin Graham Capital Management |
Trimmed | 839 | $444,326 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 26 |
| Q1 2026 | 26 |
| Q4 2025 | 27 |
| Q3 2025 | 26 |
| Q2 2025 | 26 |
| Q1 2025 | 27 |
| Q4 2024 | 25 |
| Q3 2024 | 25 |
Questions about Medpace
Which superinvestors own Medpace?
25 of the superinvestors we track hold Medpace (MEDP) in their latest 13F filings, $2.5B in total. Cliff Asness, Wasatch, Baillie Gifford, Arrowstreet Capital, Jim Simons, Francois Rochon.
Who is the largest superinvestor holder of MEDP?
The largest holder is Cliff Asness (AQR Capital Management), with $677M, 0.2% of the portfolio.
From Medpace's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.